Education
About Us
Working with TipRanks
Follow Us
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
KIDS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$16.59 - $33.14
Previous CloseN/A
Volume20.12K
Average Volume (3M)169.85K
Market Cap
$481.16M
Enterprise Value$529.72M
Total Cash (Recent Filing)$70.15M
Total Debt (Recent Filing)$97.17M
Price to Earnings (P/E)―
Beta0.90
Next Earnings
Nov 05, 2025EPS Estimate
-0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding25,073,603
10 Day Avg. Volume204,887
30 Day Avg. Volume169,853
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.10
Enterprise Value/Revenue2.40
Enterprise Value/Gross Profit3.35
Enterprise Value/Ebitda-31.65
Forecast
1Y Price Target
$32.14Price Target Upside67.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Bulls Say, Bears Say
Bulls Say
Market PositionPhysician feedback for KIDS' products continues to be extremely positive and emphasizes its dominant position in the pediatric orthopedic market.
Product DevelopmentDevelopment of new products are also receiving positive early feedback, highlighting KIDS' dedication to pediatric orthopedics.
ValuationKIDS shares trade at 1.7x NTM EV/Sales, below high-growth peers at 5.5x NTM EV/Sales, indicating potential for multiple expansion as growth sustains.
Bears Say
Costs And ProfitabilityThe company is exposed to tariffs which could impact costs and profitability.
Gross MarginGross margin was down 520 bps Y/Y driven by increased international set sales and 7D placements.
OrthoPediatrics News
KIDS FAQ
What was OrthoPediatrics Corp’s price range in the past 12 months?
OrthoPediatrics Corp lowest stock price was $16.59 and its highest was $33.14 in the past 12 months.
What is OrthoPediatrics Corp’s market cap?
OrthoPediatrics Corp’s market cap is $481.16M.
When is OrthoPediatrics Corp’s upcoming earnings report date?
OrthoPediatrics Corp’s upcoming earnings report date is Nov 05, 2025 which is in 78 days.
How were OrthoPediatrics Corp’s earnings last quarter?
OrthoPediatrics Corp released its earnings results on Aug 05, 2025. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.29 by $0.18.
Is OrthoPediatrics Corp overvalued?
According to Wall Street analysts OrthoPediatrics Corp’s price is currently Undervalued.
Does OrthoPediatrics Corp pay dividends?
OrthoPediatrics Corp does not currently pay dividends.
What is OrthoPediatrics Corp’s EPS estimate?
OrthoPediatrics Corp’s EPS estimate is -0.25.
How many shares outstanding does OrthoPediatrics Corp have?
OrthoPediatrics Corp has 25,073,603 shares outstanding.
What happened to OrthoPediatrics Corp’s price movement after its last earnings report?
OrthoPediatrics Corp reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.29. Following the earnings report the stock price went down -11.342%.
Which hedge fund is a major shareholder of OrthoPediatrics Corp?
Currently, no hedge funds are holding shares in KIDS
OrthoPediatrics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$32.14 (67.48% Upside)
$32.14 (67.48% Upside)
Blogger Sentiment
Bullish
KIDS Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 8.3K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.57%
12-Months-Change
Fundamentals
Return on Equity
-11.49%
Trailing 12-Months
Asset Growth
16.91%
Trailing 12-Months
Company Description
OrthoPediatrics Corp
OrthoPediatrics (KIDS) is a leading medical device company focused on advancing the field of pediatric orthopedics. The company specializes in developing and providing innovative surgical solutions for children with musculoskeletal conditions, including trauma, deformities, and spinal disorders. OrthoPediatrics offers a comprehensive range of products including implants, instrumentation, and surgical tools designed specifically for the anatomical and physiological needs of pediatric patients, thereby enhancing surgical outcomes and improving the quality of care for young patients.
KIDS Company Deck
KIDS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call depicted a strong performance in terms of revenue growth, especially in the Scoliosis and OPSB segments, with promising expansions and product launches. However, challenges like a decline in gross margins and restructuring costs were noted. Overall, the positive aspects and growth initiatives appeared to outweigh the identified challenges.View all KIDS earnings summariesKIDS Stock 12 Month Forecast
Average Price Target
$32.14
▲(67.48% Upside)
Technical Analysis
Ownership Overview
33.09% Insiders
16.97% Mutual Funds
2.64% Other Institutional Investors
39.03% Public Companies and
Individual Investors